2022
DOI: 10.1038/s41556-022-00977-x
|View full text |Cite
|
Sign up to set email alerts
|

Brain-enriched RagB isoforms regulate the dynamics of mTORC1 activity through GATOR1 inhibition

Abstract: Mechanistic target of rapamycin complex 1 (mTORC1) senses nutrient availability to appropriately regulate cellular anabolism and catabolism. During nutrient restriction, different organs in an animal do not respond equally, with vital organs being relatively spared. This raises the possibility that mTORC1 is differentially regulated in different cell types, yet little is known about this mechanistically. The Rag GTPases, RagA or RagB bound to RagC or RagD, tether mTORC1 in a nutrient-dependent manner to lysoso… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
16
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(18 citation statements)
references
References 75 publications
1
16
0
Order By: Relevance
“…However, they may provide sites for post-translational modifications or interaction motifs for regulatory proteins, as we report here for p18 preferentially binding to RagD. Accordingly, in an accompanying paper, Figlia et al reveal that RagB isoforms maintain active mTORC1 in starved neurons or various tumours by inhibiting GATOR1, the RagA/B GTPase activating protein complex 55 .…”
Section: Discussionsupporting
confidence: 68%
“…However, they may provide sites for post-translational modifications or interaction motifs for regulatory proteins, as we report here for p18 preferentially binding to RagD. Accordingly, in an accompanying paper, Figlia et al reveal that RagB isoforms maintain active mTORC1 in starved neurons or various tumours by inhibiting GATOR1, the RagA/B GTPase activating protein complex 55 .…”
Section: Discussionsupporting
confidence: 68%
“…Although patients with familial DEPDC5‐related epilepsy harbor a germline mutation, they primarily present with focal pathology in the brain 13,14 . Genetic evidence has emerged that the focal pathology is the consequence of a pathogenic germline mutation and a somatic mutation leading to mosaic biallelic DEPDC5 loss‐of‐function (LOF), 39–41 concordant with Knudson's “2‐hit” hypothesis 42 .…”
Section: Discussionmentioning
confidence: 91%
“…For example, DEPDC5 variants were found in approximately 10% of cases in a retrospective SUDEP cohort 10 . In contrast to channelopathies, DEPDC5 ‐related epilepsy primarily manifests as a focal lesion in the brain 13,14 . Whereas patients with tuberous sclerosis complex (TSC), the prototypical monogenic disorder of the mTOR pathway, develop widespread developmental lesions in the brain and other organ systems (eg, skin, heart, and kidneys), 15 patients with DEPDC5 ‐related epilepsy have no extra‐neural lesions 13,14 .…”
mentioning
confidence: 99%
“…This is surprising as PI3K is a well-known enhancer of both MTORC1 substrates (Hay and Sonenberg, 2004). Recent evidence shows that the RAG GTPases mediate MTORC1 substrate specificity towards TFEB/TFE (Alesi et al, 2021; Figlia et al, 2022; Gollwitzer et al, 2022; Li et al, 2022; Napolitano et al, 2020), but no differential effect towards RPS6KB1 versus EIF4EBP1 has been described so far. The difference in EIF4EBP1 and RPS6KB1 phosphorylation may be explained by the higher affinity of EIF4EBP1 to the MTORC1 scaffold protein RAPTOR (Bohm et al, 2021; Fumagalli and Pende, 2022), which along with increased EIF4EBP1 levels may enhance recruitment and phosphorylation by MTORC1.…”
Section: Discussionmentioning
confidence: 99%